封面
市場調查報告書
商品編碼
1571814

醫用級超高分子量聚乙烯單體市場規模、佔有率和趨勢分析報告:按應用、按地區和細分市場預測,2024-2030年

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Size, Share & Trends Analysis Report By Application (Knee Replacement, Hip Replacement), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

醫用級超高分子量聚乙烯單體市場成長與趨勢:

根據Grand View Research, Inc.最新報告顯示,到2030年,全球醫用級超高分子量聚乙烯單體市場規模將達到41.6億美元,2024年至2030年複合年成長率為9.5%。

由於其優異的性能,如高衝擊強度、低反應性和良好的柔韌性,這種材料在醫療植入中的有效性預計將在預測期內推動其需求。

UHMWPE 是一種長鏈材料,可實現有效的負載轉移,使其適合植入應用。這種材料非常柔韌並且具有很高的衝擊強度。它也比金屬輕。由於所有這些特性,近年來醫療應用中對 UHMWPE 的需求有所增加,預計這一趨勢在預測期內將持續下去。

超高分子量聚乙烯因其有效性和多功能性而被用於關節重建手術。世界各地對關節重建手術的需求正在迅速增加。老年人口的增加、生活方式的改變以及身體素質的缺乏是造成這一趨勢的因素。預計這一趨勢將對未來八年的整體需求產生積極影響。

主要行業參與者正在尋求開發具有更長壽命、更高舒適度和更強機械性能的創新植入產品。該市場的特點是少數公司佔據了壓倒性的收益佔有率。公司正在努力擴大產品系列和生產能力,以滿足不斷成長的需求。

醫療級超高分子量聚乙烯單體市場報告要點

  • 由於骨關節炎和其他關節相關疾病的盛行率不斷增加,到2023年,全膝關節關節重建手術將佔40.9%的壓倒性佔有率。
  • 由於骨關節炎和類風濕性關節炎盛行率不斷上升,預計全髖置換術在預測期內將以最快的複合年成長率成長。
  • 亞太地區醫用級超高分子量聚乙烯單體市場2023年市場佔有率為40.5%。
  • 北美醫用級超高分子量聚乙烯單體市場2023年市場佔有率為26.0%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章醫用級超高分子量聚乙烯 (UHMWPE) 單體市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 醫用級超高分子量聚乙烯 (UHMWPE) 單體市場分析工具
    • 波特的分析
    • PESTEL分析

第4章醫用級超高分子量聚乙烯(UHMWPE)單體市場:應用估算與趨勢分析

  • 細分儀表板
  • 醫用級超高分子量聚乙烯 (UHMWPE) 單體市場:應用變化分析,百萬美元,數量:千噸,2023 年和 2030 年
  • 全髖置換術
  • 膝關節關節重建
  • 肩關節關節重建
  • 腳踝置換術
  • 小關節

第5章醫用級超高分子量聚乙烯(UHMWPE)單體市場:區域估計與趨勢分析

  • 2023 年和 2030 年醫用級超高分子量聚乙烯 (UHMWPE) 單體按地區市場佔有率,百萬美元,數量:千噸
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 印尼
    • 越南
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭狀況

  • 最新趨勢與影響分析:主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Celanese Corporation
    • DSM Biomedical
    • Honeywell International Inc.
    • Mitsui Chemicals, Inc.
    • TEIJIN LIMITED
    • LyondellBasell Industries Holdings BV
    • Orthoplastics Ltd.
    • Tianyi Biomedical Technology Co., Ltd.
    • Quadrant Engineering Plastic Products(Mitsubishi Chemical Advanced Materials)
    • Asahi Kasei Corporation
簡介目錄
Product Code: GVR-1-68038-272-3

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Growth & Trends:

The global medical grade ultra high molecular weight polyethylene monomer market size is expected to reach USD 4.16 billion by 2030, registering a CAGR of 9.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The effectiveness of the material in medical implants due to its superior properties such as high impact strength, low reactivity, and good flexibility is expected to drive the demand over the forecast period.

UHMWPE is a material having long chains which enable it to efficiently transfer load, thus making it suitable for implantation applications. The material is extremely pliable and has good impact strength. The material has less weight as compared to metals. All these properties have increased the demand for UHMWPE for medical applications in the recent past, and this trend is expected to continue over the forecast period.

Joint replacement surgeries use ultra high molecular weight polyethylene due to its effectiveness and versatility options. There has been a surge in demand for joint replacement surgeries across the globe. Rising geriatric population, changing lifestyle and lack of fitness are the contributing factors for this trend. This trend is expected to benefit the overall demand over next eight years.

Major industry participants are trying to develop innovative implantable products which have a longer life, are more comfortable, and give a strong mechanical performance. The market is characterized by few companies occupying a dominant revenue share. Companies are taking steps to increase the product portfolio and production capacity to meet the rising demand.

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Report Highlights:

  • Knee replacements have accounted for the dominant share of 40.9% in 2023 owing to the increasing prevalence of osteoarthritis and other joint-related conditions.
  • Total hip replacement surgeries are expected to emerge at the fastest-growing CAGR during the forecast period owing to the escalating prevalence of osteoarthritis and rheumatoid arthritis.
  • The medical grade ultra high molecular weight polyethylene monomers market in Asia Pacific registered 40.5% as the dominant market share in 2023.
  • The North America medical grade ultra high molecular weight polyethylene monomers market secured 26.0% of the market share in 2023 owing to the region's growing investment in the healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million) (Volume in Kilotons)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Movement Analysis, USD Million, Volume in Kilotons, 2023 & 2030
  • 4.3. Total Hip Replacement
    • 4.3.1. Total Hip Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.4. Knee Replacement
    • 4.4.1. Knee Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.5. Shoulder Replacement
    • 4.5.1. Shoulder Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.6. Ankle Replacement
    • 4.6.1. Ankle Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.7. Small Joints
    • 4.7.1. Small Joints Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 5. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Regional Estimates & Trend Analysis

  • 5.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer tMarket Share, By Region, 2023 & 2030, USD Million, Volume in Kilotons
  • 5.2. North America
    • 5.2.1. North America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.3. Canada
      • 5.2.3.1. Canada Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.4. Mexico
      • 5.2.4.1. Mexico Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3. Europe
    • 5.3.1. Europe Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.2. U.K.
      • 5.3.2.1. U.K. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.3. Germany
      • 5.3.3.1. Germany Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.4. France
      • 5.3.4.1. France Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.5. Italy
      • 5.3.5.1. Italy Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.6. Spain
      • 5.3.6.1. Spain Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.7. Russia
      • 5.3.7.1. Russia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.8. Demark
      • 5.3.8.1. Denmark Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.9. Sweden
      • 5.3.9.1. Sweden Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.10. Norway
      • 5.3.10.1. Norway Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.2. China
      • 5.4.2.1. China Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.3. Japan
      • 5.4.3.1. Japan Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.4. India
      • 5.4.4.1. India Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.5. Australia
      • 5.4.5.1. Australia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.7. Indonesia
      • 5.4.7.1. Indonesia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.8. Vietnam
      • 5.4.8.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.5. Latin America
    • 5.5.1. Latin America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.5.3. Argentina
      • 5.5.3.1. Argentina Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.6. Middle East and Africa
    • 5.6.1. Middle East and Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Saudi Arabia
      • 5.6.2.1. Saudi Arabia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.3. South Africa
      • 5.6.3.1. South Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.4. UAE
      • 5.6.4.1. UAE Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Heat Map Analysis
  • 6.4. Company Profiles
    • 6.4.1. Celanese Corporation
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Recent Developments/ Strategic Initiatives
    • 6.4.2. DSM Biomedical
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Recent Developments/ Strategic Initiatives
    • 6.4.3. Honeywell International Inc.
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Recent Developments/ Strategic Initiatives
    • 6.4.4. Mitsui Chemicals, Inc.
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Recent Developments/ Strategic Initiatives
    • 6.4.5. TEIJIN LIMITED
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Recent Developments/ Strategic Initiatives
    • 6.4.6. LyondellBasell Industries Holdings B.V.
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Recent Developments/ Strategic Initiatives
    • 6.4.7. Orthoplastics Ltd.
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Recent Developments/ Strategic Initiatives
    • 6.4.8. Tianyi Biomedical Technology Co., Ltd.
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Recent Developments/ Strategic Initiatives
    • 6.4.9. Quadrant Engineering Plastic Products (Mitsubishi Chemical Advanced Materials)
      • 6.4.9.1. Participant's Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Recent Developments/ Strategic Initiatives
    • 6.4.10. Asahi Kasei Corporation
      • 6.4.10.1. Participant's Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Recent Developments/ Strategic Initiatives